- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SNY
Recent news which mentions SNY
FDA Approves Sanofi's Hemophilia Drug
March 31, 2025
From Benzinga
From Benzinga
This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
March 21, 2025
From Benzinga
Sanofi Strengthens Its Immune System-Focused Pipeline With Around $2 Billion Dren Bio Deal
March 20, 2025
From Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
March 18, 2025
From Benzinga
Sanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light: Can The Bullish Run Continue?
March 12, 2025
From Benzinga
Merck Injects $1 Billion To Expand Vaccine Production In US
March 11, 2025
From Benzinga
Top 3 Health Care Stocks That May Keep You Up At Night In Q1
March 11, 2025
From Benzinga
From Benzinga
Eli Lilly's Single Monthly Maintenance Shot Of Eczema Drug Shows Completely Clear Skin At 3 Years In 50% Of Trial Patients
March 07, 2025
From Benzinga
Apogee Therapeutics' Investigational Atopic Dermatitis Potential Shows Strong Tolerability, Extended Half-Life in Early Trial
March 03, 2025
From Benzinga
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value
February 27, 2025
From Benzinga
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
February 24, 2025
From Benzinga
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
February 18, 2025
From Benzinga
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
February 13, 2025
From Benzinga
Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
February 04, 2025
From Motley Fool
Sanofi Buys Back ~$3 Billion In Shares From L'Oréal: Details
February 03, 2025
From Benzinga
Earnings Scheduled For January 30, 2025
January 30, 2025
From Benzinga
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
January 28, 2025
From Benzinga
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
January 28, 2025
From Benzinga
From Benzinga
Price Over Earnings Overview: Sanofi
January 10, 2025
From Benzinga
Sanofi's Blood Cancer Drug's New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma
January 09, 2025
From Benzinga
From Benzinga
A Look Into Sanofi Inc's Price Over Earnings
December 25, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.